Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Related Articles
Click here to return to the article.
-
Pfizer raises full-year outlook, stock rises on Q1 beat
Yahoo Finance -
More Related Articles
-
Pfizer Stock Jumps After Pharma Giant Raises Outlook On Big Quarterly Beatby Investor's Business Daily